Warning: The NCBI web site requires JavaScript to function. more...
Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.
Whitty CJ, Chandler C, Ansah E, Leslie T, Staedke SG.
Malar J. 2008 Dec 11;7 Suppl 1:S7. Review.
Related citations
Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
Mutabingwa TK.
Acta Trop. 2005 Sep;95(3):305-15. Review.
Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.
Ogbonna A, Uneke CJ.
Trans R Soc Trop Med Hyg. 2008 Jul;102(7):621-7. Epub 2008 May 21. Review.
Cost of increasing access to artemisinin combination therapy: the Cambodian experience.
Yeung S, Van Damme W, Socheat D, White NJ, Mills A.
Malar J. 2008 May 20;7:84.
Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ.
Malar J. 2008 Nov 2;7:229.
Barriers to prompt and effective malaria treatment among the poorest population in Kenya.
Chuma J, Okungu V, Molyneux C.
Malar J. 2010 May 27;9:144.
Out with the old, in with the new: the utility of rapid diagnostic tests for malaria diagnosis in Africa.
Drakeley C, Reyburn H.
Trans R Soc Trop Med Hyg. 2009 Apr;103(4):333-7. Epub 2008 Nov 18.
Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.
Malar J. 2009 Jan 5;8:2.
Anti-malarial market and policy surveys in sub-Saharan Africa.
Diap G, Amuasi J, Boakye I, Sevcsik AM, Pecoul B.
Malar J. 2010 Apr 23;9 Suppl 1:S1.
The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania.
Njau JD, Goodman CA, Kachur SP, Mulligan J, Munkondya JS, McHomvu N, Abdulla S, Bloland P, Mills A.
Malar J. 2008 Jan 7;7:4.
Qinghaosu (artemisinin): the price of success.
White NJ.
Science. 2008 Apr 18;320(5874):330-4. Review.
Access to artemisinin combination therapy for malaria in remote areas of Cambodia.
Malar J. 2008 May 29;7:96.
Pharmacovigilance of antimalarial treatment in Africa: is it possible?
Talisuna AO, Staedke SG, D'Alessandro U.
Malar J. 2006 Jun 16;5:50.
Artemisinin-based combination treatment for malaria in Africa: no perfect solutions.
Whitty CJ, Staedke SG.
Clin Infect Dis. 2005 Oct 15;41(8):1087-8. Epub 2005 Sep 13. No abstract available.
Controlling malaria: challenges and solutions.
Olliaro P, Taylor WR, Rigal J.
Trop Med Int Health. 2001 Nov;6(11):922-7.
Artemisinins in malaria treatment in the UK.
[No authors listed]
Drug Ther Bull. 2010 Nov;48(11):129-32. Review.
[Treatment of pediatric malaria in Africa: act at issue].
Faucher JF, Missinou MA, Brasseur P.
Med Trop (Mars). 2006 Jun;66(3):292-4. Review. French.
Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.
Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC.
PLoS Med. 2008 Nov 25;5(11):e226; discussion e226.
The quest for universal access to effective malaria treatment: how can the AMFm contribute?
Matowe L, Adeyi O.
Malar J. 2010 Oct 8;9:274.
Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa.
Snow RW, Eckert E, Teklehaimanot A.
Trends Parasitol. 2003 Aug;19(8):363-9. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on